Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.06
-0.14 (-2.69%)
At close: Aug 14, 2026, 4:00 PM EDT
5.16
+0.10 (1.98%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $327.37 million as of August 14, 2026. Its market cap has increased by 179.93% in one year.
Market Cap
327.37M
Enterprise Value
148.33M
1-Year Change
179.93%
Ranking
Category
Stock Price
$5.06
ChartMarket Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $327.37M, a decrease of -10.52%. That is a compound annual growth rate of -2.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 327.37M | -22.95% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 364.00M |
| Abeona Therapeutics | 362.83M |
| Sutro Biopharma | 353.34M |
| Century Therapeutics | 349.48M |
| Vicore Pharma Holding AB | 343.68M |
| Clinuvel Pharmaceuticals | 341.43M |
| SAB Biotherapeutics | 341.20M |
| Lyell Immunopharma | 336.70M |